Insider buying
~$4M184K sh @ $21.70
Traded Nov 4, 2024 · filed 2 days later
A major shareholder of Bright Minds Biosciences paid $4M out of pocket for Bright Minds Biosciences shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 15, 2024 · Filed Oct 17, 2024
A major shareholder of Bright Minds Biosciences paid $57K out of pocket for Bright Minds Biosciences shares. It was the first purchase in over a year.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$56,927
Shares × reported transaction price
$25K–$100K
+0.6%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 12 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.7% | −0.9% | +4.6% |
| 30 days | −22.8% | +0.6% | −23.4% |
| 90 days | −22.5% | +1.2% | −23.7% |
| 180 days | −32.2% | −10.1% | −22.1% |
| 365 days | +39.2% | +14.8% | +24.4% |
Past results only. Not a forecast.
Insider buying
Traded Nov 4, 2024 · filed 2 days later
A major shareholder of Bright Minds Biosciences paid $4M out of pocket for Bright Minds Biosciences shares.
Insider buying
Traded Oct 16, 2024 · filed 1 day later
A major shareholder of Bright Minds Biosciences paid $923K out of pocket for Bright Minds Biosciences shares.
Insider buying
Traded Oct 15, 2024 · filed 2 days later
A major shareholder of Bright Minds Biosciences paid $65K out of pocket for Bright Minds Biosciences shares. It was the first purchase in over a year.
Cormorant Asset Management, LP, 10% owner's past purchases, 90 days after disclosure: 4 buys, median −27.4 pts vs S&P 500, beat it 0 of 4 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.